ArticleBMC cancer2026

SENIPERA Phase 0/1 randomized window-of-opportunity clinical trial of SENIcapoc and PERAmpanel mono- and combination therapy of newly diagnosed glioblastoma: a trial protocol.

Jens Toft Eschen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.